Statistics

Number of Journals8
Number of Issues50
Number of Articles363
Article View92,860
PDF Download60,637
Masoumi, M., Akiash, N., Lalvand, A., Azizidoost, S., Abbaspour, S. (2025). stem/stromal Cell-derived Exosomes: Therapeutic Approach for Heart Failure. Shahid Sadoughi University of Medical Sciences- Journal Management System, 1(3), 216-223. doi: 10.22034/jrb.2025.528.1021
Mahlasadat Masoumi; Nehzat Akiash; Atefeh Lalvand; Shirin Azizidoost; Somayeh Abbaspour. "stem/stromal Cell-derived Exosomes: Therapeutic Approach for Heart Failure". Shahid Sadoughi University of Medical Sciences- Journal Management System, 1, 3, 2025, 216-223. doi: 10.22034/jrb.2025.528.1021
Masoumi, M., Akiash, N., Lalvand, A., Azizidoost, S., Abbaspour, S. (2025). 'stem/stromal Cell-derived Exosomes: Therapeutic Approach for Heart Failure', Shahid Sadoughi University of Medical Sciences- Journal Management System, 1(3), pp. 216-223. doi: 10.22034/jrb.2025.528.1021
Masoumi, M., Akiash, N., Lalvand, A., Azizidoost, S., Abbaspour, S. stem/stromal Cell-derived Exosomes: Therapeutic Approach for Heart Failure. Shahid Sadoughi University of Medical Sciences- Journal Management System, 2025; 1(3): 216-223. doi: 10.22034/jrb.2025.528.1021

stem/stromal Cell-derived Exosomes: Therapeutic Approach for Heart Failure

Regenerative Biomedicine
Volume 1, Issue 3, July 2025, Pages 216-223    PDF (904.51 K)
Document Type: Mini-Review
DOI: 10.22034/jrb.2025.528.1021
Authors
Mahlasadat Masoumi* 1; Nehzat Akiash1; Atefeh Lalvand1; Shirin Azizidoost2; Somayeh Abbaspour3
1Cardiologist, Fellowship of Advanced Echocardiography, Atherosclerosis Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2Atherosclerosis Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3Cardiologist, Fellowship of Heart Failure and Cardiac Transplantation, Atherosclerosis Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Abstract
Heart failure remains a notable clinical and public health challenge worldwide. Current treatment modalities have shown limited success in reducing morbidity and mortality rates, highlighting the urgent need for alternative and novel therapeutic approaches. Growing evidence suggests that stem cell-derived exosomes, membrane-bound extracellular vesicles, are emerging as promising candidates for treating heart failure. Exosome released from mesenchymal stem cells and induced pluripotent stem cells (iPSCs) have demonstrated cardioprotective, immunomodulatory, and reparative effects. key advantages include targeted delivery, reduced immunogenicity, decreased tumor formation risk, and improvement storage and transportation feasibility. Despite their promise, challenges such as low production yield, stability concerns, and efficient delivery methods remain. standard methods for exosome isolation and characterization is needed. This mini-review summarizes stem cell-derived exosomes with potential applications in heart failure. Modifying exosome contents by regulating specific microRNA (miRNAs) can modulate communication between cardiac cells, often resulting in improved cardioprotection through various signaling pathways. The underling mechanism of these pathways encompasses enhancing angiogenesis, apoptosis inhibition, and fibrosis reduction.
Keywords
Cardiac Repair; Embryonic Stem Cells (ESCs); Exosome; Mesenchymal Stem Cells (MSCs); Pluripotent Stem Cells (PSCs)
Statistics
Article View: 1


Journal Management System. Powered by Sinaweb